ES8106489A1 - Un procedimiento para la preparacion de un derivado de 15 sulfonamidoprostaglandina. - Google Patents
Un procedimiento para la preparacion de un derivado de 15 sulfonamidoprostaglandina.Info
- Publication number
- ES8106489A1 ES8106489A1 ES495101A ES495101A ES8106489A1 ES 8106489 A1 ES8106489 A1 ES 8106489A1 ES 495101 A ES495101 A ES 495101A ES 495101 A ES495101 A ES 495101A ES 8106489 A1 ES8106489 A1 ES 8106489A1
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- methanesulfonamidoprostaglandin
- pharmaceutical compositions
- process therefor
- diluted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- SXXLKZCNJHJYFL-UHFFFAOYSA-N 4,5,6,7-tetrahydro-[1,2]oxazolo[4,5-c]pyridin-5-ium-3-olate Chemical compound C1CNCC2=C1ONC2=O SXXLKZCNJHJYFL-UHFFFAOYSA-N 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 abstract 1
- 102100034195 Thrombopoietin Human genes 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE 15-SULFONAMIDOPROSTAGLANDINA. CONSISTE EN HACER REACCIONAR UN ACIDO ALCANOICO DILUIDO DE 2 A 4 ATOMOS DE CARBONO Y AGUA CON UN INTERMEDIARIO DE FORMULA GENERAL (I), EN QUE THPO ES TETRAHIDRPIRANITOXI, HIDROLIZANDO CON ELLO EL GRUPO THPO. SE OBTIENE EL COMPUESTO DE FORMULA GENERAL (II), EN QUE Q ES -CO2H1-CO2R1TETRAZOL-5-ILO-CONHSO2R; A ES ETILENO O CIS-VINILENO; X ES H, F, CL, BR, OCH3, CF3 O CH3; R ES ALQUILO DE 1 A 4 ATOMOS DE CARBONO O FENILO. EL ACIDO EMPLEADO ES EL ACETICO DILUIDO EN AGUA. *FORMULA* N
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/076,520 US4232173A (en) | 1979-09-17 | 1979-09-17 | 15-Sulfonamidoprostaglandin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES495101A0 ES495101A0 (es) | 1981-08-16 |
ES8106489A1 true ES8106489A1 (es) | 1981-08-16 |
Family
ID=22132532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES495101A Expired ES8106489A1 (es) | 1979-09-17 | 1980-09-16 | Un procedimiento para la preparacion de un derivado de 15 sulfonamidoprostaglandina. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4232173A (es) |
EP (1) | EP0025687B1 (es) |
JP (1) | JPS5951938B2 (es) |
KR (1) | KR840000964B1 (es) |
AR (1) | AR225776A1 (es) |
AT (1) | ATE1858T1 (es) |
AU (1) | AU518068B2 (es) |
CA (1) | CA1153368A (es) |
DE (1) | DE3061160D1 (es) |
DK (1) | DK392580A (es) |
ES (1) | ES8106489A1 (es) |
FI (1) | FI68615C (es) |
GR (1) | GR70288B (es) |
IE (1) | IE50266B1 (es) |
IL (1) | IL61038A (es) |
PH (1) | PH15098A (es) |
PT (1) | PT71807B (es) |
YU (1) | YU236180A (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61126069A (ja) * | 1984-11-21 | 1986-06-13 | Res Dev Corp Of Japan | プロスタグランジン誘導体 |
JPS63207015A (ja) * | 1987-02-23 | 1988-08-26 | 株式会社日立製作所 | 遮断器装置 |
JPS6429564A (en) * | 1987-07-25 | 1989-01-31 | Oyo Kikaku Kk | Common joist mechanism |
US5387608A (en) * | 1993-08-17 | 1995-02-07 | Allergan, Inc. | Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents |
US5607415A (en) * | 1994-08-18 | 1997-03-04 | Kimberly-Clark Corporation | Flexible absorbent article |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3835179A (en) * | 1972-07-24 | 1974-09-10 | American Cyanamid Co | Novel 15-substituted prostanoic acids and esters |
US4033996A (en) * | 1973-04-25 | 1977-07-05 | Merck & Co., Inc. | 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins |
GB1507211A (en) * | 1975-02-14 | 1978-04-12 | Ono Pharmaceutical Co | Prostaglandin analogues |
-
1979
- 1979-09-17 US US06/076,520 patent/US4232173A/en not_active Expired - Lifetime
-
1980
- 1980-09-09 EP EP80303155A patent/EP0025687B1/en not_active Expired
- 1980-09-09 DE DE8080303155T patent/DE3061160D1/de not_active Expired
- 1980-09-09 AT AT80303155T patent/ATE1858T1/de not_active IP Right Cessation
- 1980-09-15 IL IL61038A patent/IL61038A/xx unknown
- 1980-09-15 YU YU02361/80A patent/YU236180A/xx unknown
- 1980-09-15 PT PT71807A patent/PT71807B/pt unknown
- 1980-09-15 IE IE1927/80A patent/IE50266B1/en unknown
- 1980-09-15 GR GR62889A patent/GR70288B/el unknown
- 1980-09-15 CA CA000360249A patent/CA1153368A/en not_active Expired
- 1980-09-16 FI FI802904A patent/FI68615C/fi not_active IP Right Cessation
- 1980-09-16 ES ES495101A patent/ES8106489A1/es not_active Expired
- 1980-09-16 DK DK392580A patent/DK392580A/da not_active Application Discontinuation
- 1980-09-16 KR KR1019800003623A patent/KR840000964B1/ko active
- 1980-09-16 AU AU62436/80A patent/AU518068B2/en not_active Ceased
- 1980-09-16 JP JP55128465A patent/JPS5951938B2/ja not_active Expired
- 1980-09-16 PH PH24591A patent/PH15098A/en unknown
- 1980-09-17 AR AR282561A patent/AR225776A1/es active
Also Published As
Publication number | Publication date |
---|---|
GR70288B (es) | 1982-09-03 |
KR830003415A (ko) | 1983-06-20 |
AU6243680A (en) | 1981-03-26 |
FI68615C (fi) | 1985-10-10 |
CA1153368A (en) | 1983-09-06 |
IL61038A (en) | 1983-12-30 |
YU236180A (en) | 1983-01-21 |
IL61038A0 (en) | 1980-11-30 |
KR840000964B1 (ko) | 1984-07-02 |
IE50266B1 (en) | 1986-03-19 |
PT71807A (en) | 1980-10-01 |
AU518068B2 (en) | 1981-09-10 |
PT71807B (en) | 1981-07-02 |
AR225776A1 (es) | 1982-04-30 |
FI68615B (fi) | 1985-06-28 |
JPS5651448A (en) | 1981-05-09 |
US4232173A (en) | 1980-11-04 |
DE3061160D1 (en) | 1982-12-30 |
EP0025687A1 (en) | 1981-03-25 |
IE801927L (en) | 1981-03-17 |
ATE1858T1 (de) | 1982-12-15 |
EP0025687B1 (en) | 1982-11-24 |
JPS5951938B2 (ja) | 1984-12-17 |
ES495101A0 (es) | 1981-08-16 |
DK392580A (da) | 1981-03-18 |
FI802904A (fi) | 1981-03-18 |
PH15098A (en) | 1982-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES391299A1 (es) | Procedimiento para la preparacion de n-alil 2 - arilamino -imidazolinas (2) sustituidas. | |
ES456541A1 (es) | Procedimiento para la preparacion de acidos n-fosfonometilen-monoaminoalcanmonofosfonicos y -polifosfonicos yno acidos n-fosfonometilen-diaminoalcanpolifosfonicos. | |
ES368572A1 (es) | Un procedimiento para preparar el 2-(6'-metoxi-2'-naftil) propanal. | |
ES8507484A1 (es) | Procedimiento de producir compuestos beta-lactamicos y similares | |
ES8106489A1 (es) | Un procedimiento para la preparacion de un derivado de 15 sulfonamidoprostaglandina. | |
SE7706206L (sv) | Forfarande for framstellning av polyperenylkarbonsyraforeningar | |
ES449817A1 (es) | Procedimiento para producir 2-fenilamino-tiazolinas susti- tuidas. | |
ES436157A1 (es) | Un procedimiento para la preparacion de compuestos de indo- lina. | |
ES472511A1 (es) | Procedimiento para la obtencion de derivados del acido 13 tianoprostanico | |
ATE18208T1 (de) | N-(4-hydroxyphenyl)essigsaeureamid-estern aus 5benzoyl-1-methylpyrrol-2-essigsaeure. | |
ES432790A1 (es) | Un metodo para producir derivados del acido 2-cloropropioni-co. | |
DK82583A (da) | Furyloxazolyleddikesyrederivater og fremgangsmaader til fremstilling deraf | |
ES441257A1 (es) | Procedimiento para preparar aminocicloles. | |
ES440282A1 (es) | Procedimiento para la preparacion de piperidina. | |
ES444439A1 (es) | Procedimiento para la obtencion de carbonatos de cetooxima. | |
ES440831A1 (es) | Un procedimiento de obtencion de nuevos acidos bencilamino alcanoicos. | |
ES421284A1 (es) | Procedimiento para la preparacion de derivados de acidos pirrocolinaceticos. | |
ES8203879A1 (es) | Procedimiento para preparar butirolactonas. | |
ES406726A1 (es) | Un procedimiento para preparar dimetilsulfoxidos y dimetil-sulfonas de acido benzoico sustituido. | |
ES459871A1 (es) | Procedimiento para la obtencion de sales de hidrocarbil-tio-etilaminas. | |
ES477163A1 (es) | Procedimiento para la preparacion de compuestos de acidos 4-(8x-6,11-dihidro-dibenzo- b.e. -tiepin-11-on-3-il)-4-oxobu- tiricos. | |
ES383342A1 (es) | Procedimiento para la preparacion de nuevos derivados de labencensulfonamida. | |
ES417883A1 (es) | Procedimiento para la preparacion de derivados de bifenilo. | |
ES479710A1 (es) | Procedimiento para preparar un acido cromon-2-carboxilico. | |
ES478666A1 (es) | Procedimiento para preparar derivados del acido oxamico. |